Skip to main content

Table 1 (Abstract A19). Characteristics of the BECOME study population in Part 1

From: 13th European Headache Federation Congress 2019 - Abstracts

 Part 1 (N=20,837)
Prior prophylactic treatment failures
 No PPTF7880 (37.8)
 ≥1 PPTF12,957 (62.2)
  1 PPTF4137 (19.9)
  2 PPTF3063 (14.7)
  3 PPTF2244 (10.8)
  ≥4 PPTF3513 (16.9)
Monthly migraine days
 <4 MMD5358 (25.7)
 ≥4 MMD15,479 (74.3)
  4–7 MMD5796 (27.8)
  8–14 MMD4916 (23.6)
  ≥15 headache days, of which ≥8 were MMD4767 (22.9)
First visit versus follow-up visit patients
 First visit5621 (27.0)
 Follow-up visit15,216 (73.0)
Medication overuse
 Any medication overuse3706 (17.8)
 Any suspected medication overuse headache2464 (11.8)
Outpatients versus inpatients
 Outpatient visits19,700 (94.5)
 Inpatient visits650 (3.1)
 Unclassified visits487 (2.3)
  1. All values are n (%) of patients
  2. MMD, monthly migraine days; N, total number of patients; n, number of patients; PPTF, prior prophylactic treatment failures
\